Search - tctmd.com

Displaying 421 - 440 of 673

Sort: Relevancy | Date

News Daily News

Study Suggests MI Prevention Efforts Slipping, as Certain Risk Factors Creep Higher

L.A. McKeown

March 28, 2016

News Daily News

Un Sistema de Puntuación Simplifica la Valoración del Riesgo para la Muerte Cardíaca Súbita Post-SCASEST

L.A. McKeown

March 18, 2016

News Daily News

Scoring System Simplifies Risk Assessment for Sudden Cardiac Death After NSTE ACS

L.A. McKeown

March 18, 2016

News Daily News

Una Calculadora Estima el Riesgo de IM Espontáneo en Pacientes Víctimas de SCASEST Tratados Médicamente

Todd Neale

March 16, 2016

News Daily News

Calculator Estimates Spontaneous MI Risk in Medically Managed NSTE ACS Patients

Todd Neale

March 16, 2016

News Conference News CRT 2016

STEMI Mortality Risk Doubled in Women, Even in North America, Europe

Shelley Wood

February 20, 2016

News Daily News

Meta Análisis: La Revascularización Completa Reduce la Mortalidad, los IM y las Nuevas Intervenciones en la EAC Multivaso

Michael O'Riordan

January 21, 2016

News Daily News

Complete Revascularization Reduces Mortality, MI, and Repeat Procedures in Multivessel CAD: Meta-Analysis

Michael O'Riordan

January 21, 2016

News Daily News

PCI for Cardiogenic Shock: Mortality Has Increased, but So Has Patient Risk

Yael L. Maxwell

January 20, 2016

News Daily News

Former FDA Staffer Says Missing Data Across Antithrombotic Trials Cast Doubt on Drug Effects

Shelley Wood

January 18, 2016

News Daily News

Symptom Duration May Be More Important Than D2B for STEMI, HORIZONS-AMI Substudy Suggests

Yael L. Maxwell

January 05, 2016

News Daily News

La Duración de los Síntomas Podría ser Más Importante que el Tiempo Puerta-Balón en el Manejo de Los Cuadros de STEMI, según un Subestudio del HORIZONS-AMI

Yael L. Maxwell

January 05, 2016

News Daily News

Prometedores Primeros Datos para el Fármaco Antiplaquetario Reversible de Acción Rápida PZ-128

Caitlin E. Cox

December 20, 2015

News Daily News

Early Data Show Promise for Reversible, Fast-Acting, Antiplatelet Drug PZ-128

Caitlin E. Cox

December 20, 2015

News Daily News

依泽替米贝减少心血管事件的说法未能获得 FDA 顾问委员会的支持

Michael O'Riordan

December 15, 2015

News Daily News

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

Michael O'Riordan

December 15, 2015

News Daily News

Negative Statin-Related News Linked With Drug Discontinuation, Increased CV Risk

Michael O'Riordan

December 02, 2015

News Daily News

Las Noticias Negativas sobre las Estatinas se asociaron a su Interrupción y a Más Riesgo CV

Michael O'Riordan

December 02, 2015

News Daily News

Medicare Part D Has Scant Effect on Outcomes for Acute MI Patients

Yael L. Maxwell

November 04, 2015

News Conference News TCT 2015

Thrombus Aspiration Fails to Reduce Microvascular Obstruction in Subacute STEMI

October 13, 2015

Advertisement

Study Suggests MI Prevention Efforts Slipping, as Certain Risk Factors Creep Higher

Un Sistema de Puntuación Simplifica la Valoración del Riesgo para la Muerte Cardíaca Súbita Post-SCASEST

Scoring System Simplifies Risk Assessment for Sudden Cardiac Death After NSTE ACS

Una Calculadora Estima el Riesgo de IM Espontáneo en Pacientes Víctimas de SCASEST Tratados Médicamente

Calculator Estimates Spontaneous MI Risk in Medically Managed NSTE ACS Patients

STEMI Mortality Risk Doubled in Women, Even in North America, Europe

Meta Análisis: La Revascularización Completa Reduce la Mortalidad, los IM y las Nuevas Intervenciones en la EAC Multivaso

Complete Revascularization Reduces Mortality, MI, and Repeat Procedures in Multivessel CAD: Meta-Analysis

PCI for Cardiogenic Shock: Mortality Has Increased, but So Has Patient Risk

Former FDA Staffer Says Missing Data Across Antithrombotic Trials Cast Doubt on Drug Effects

Symptom Duration May Be More Important Than D2B for STEMI, HORIZONS-AMI Substudy Suggests

La Duración de los Síntomas Podría ser Más Importante que el Tiempo Puerta-Balón en el Manejo de Los Cuadros de STEMI, según un Subestudio del HORIZONS-AMI

Prometedores Primeros Datos para el Fármaco Antiplaquetario Reversible de Acción Rápida PZ-128

Early Data Show Promise for Reversible, Fast-Acting, Antiplatelet Drug PZ-128

依泽替米贝减少心血管事件的说法未能获得 FDA 顾问委员会的支持

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

Negative Statin-Related News Linked With Drug Discontinuation, Increased CV Risk

Las Noticias Negativas sobre las Estatinas se asociaron a su Interrupción y a Más Riesgo CV

Medicare Part D Has Scant Effect on Outcomes for Acute MI Patients

Thrombus Aspiration Fails to Reduce Microvascular Obstruction in Subacute STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content